Economic evaluation of pemetrexed versus erlotinib as second-line treatment of patients with advanced/metastatic non-small cell lung cancer in Greece: a cost minimization analysis
VF Fragoulakis,1 AG Pallis,3 DK Kaitelidou,2 NM Maniadakis,1 VG Georgoulias31Department of Health Services Management, National School of Public Health, Athens, 2Center for Health Services Management and Evaluation, Department of Nursing, University of Athens, Athens, Greece; 3Department of Medical...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Dove Medical Press
2012
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/f1f1582fdeaf40538ee1ef2b7b85cfe5 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|